Back to VA VANGUARD CAPITAL MANAGEMENT LLC

PTCTPTCT
2 quarters

Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in PTC THERAPEUTICS INC

Yes. Vanguard Capital Management holds 3,739,127 shares of PTCT (PTC Therapeutics), worth $305M, as of its Q2 2026 13F filing. It increased the position by 62,871 shares (+1.7%) from Q1 2026. Vanguard Capital Management has held PTCT in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$305M

Current Shares

3.7M

Total Value Change

+$54.5M

Total Shares Change

+62,871

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.7M
+1.7%
$305M0.0%$81.57
31
2026-Q1
First report
3.7M
-
$250.5M0.0%$64.39
0

Other major holders of PTCT: BlackRock, Inc., VANGUARD GROUP INC, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used